ESEuropeanSwitch
ON

Oncopeptides Sweden

Oncopeptides develops peptidase-enhanced cytotoxic agents for treatment of relapsed refractory multiple myeloma using digital clinical trial data management for its oncology pipeline.

Sweden Founded 2000 Pay-as-you-go
🏢
Is this your company? Claim this listing to update your profile and add your logo. Free to claim — Enhanced Profile from £500 / €575 per year. See an example →

About Oncopeptides Sweden

Oncopeptides develops peptidase-enhanced cytotoxic agents for treatment of relapsed refractory multiple myeloma using digital clinical trial data management for its oncology pipeline.

Provider Details

HQ Sweden
HQ City Stockholm
Founded 2000
Pricing Pay-as-you-go
Data Hosting Stockholm

Classifications